Erin Bange MD MSCE(@erin_bange) 's Twitter Profileg
Erin Bange MD MSCE

@erin_bange

GU oncologist and health services researcher | focused on improving patient centered oncology care | views are my own

ID:2800171943

calendar_today02-10-2014 15:01:41

44 Tweets

173 Followers

168 Following

H. Jack West, MD(@JackWestMD) 's Twitter Profile Photo

📢In many ways, is true patient-centered care. Fumiko Ladd Chino, MD, Erin Bange, & I wrote this piece about how health care systems highlight desire to be pt-centered but offer telemedicine sparingly or begrudgingly. Why are we not walking the walk?
rdcu.be/dfpaM

account_circle
Fumiko Ladd Chino, MD(@fumikochino) 's Twitter Profile Photo

💻📲 Rapidly deployed during the pandemic, has now been sharply scaled back. Continued offering of a visit option may allow true patient-centered care. New editorial in NatureRevClinOncol: how to walk the walk for patient access.
rdcu.be/dfpaM

💻📲 Rapidly deployed during the pandemic, #telemedicine has now been sharply scaled back. Continued offering of a #Telehealth visit option may allow true patient-centered care. New editorial in @NatRevClinOncol: how to walk the walk for patient access. rdcu.be/dfpaM
account_circle
Penn Cancer Innovation(@PC3Innovation) 's Twitter Profile Photo

: Collab w/ Flatiron Health, led by PC3I's Christopher D'avella & Lawrence Shulman w/ team David W Dougherty Erin Bange MD MSCE Aditi Singh present on value of based clinical pathways tool to improve workflow.
23 ASCO

meetings.asco.org/abstracts-pres…

#PC3IatASCO: Collab w/ @flatironhealth, led by PC3I's Christopher D'avella & Lawrence Shulman w/ team @dwdougherty31 @erin_bange @AditiSinghMD present on value of #EMR based clinical pathways tool to improve #clinician workflow. #ASCO #ASCO23 @ASCO meetings.asco.org/abstracts-pres…
account_circle
Penn Cancer Innovation(@PC3Innovation) 's Twitter Profile Photo

Do clinical pathways impede provider workflow: A provider efficiency analysis of time spent using an EHR-embedded clinical decision support tool. Abstract 381 Poster E20 meetings.asco.org/abstracts-pres…
Greg Calip Erin Bange MD MSCE Aditi Singh

pc3i.upenn.edu/pc3i-presents-…

account_circle
Fumiko Ladd Chino, MD(@fumikochino) 's Twitter Profile Photo

Dr Christopher Jenson UNC Lineberger presenting on in older patients with . High intensity treatment improved survival BUT meant most of that time was SPENT IN THE HOSPITAL and/or AWAY from HOME. ASCO
cc Dr Arjun Gupta Erin Bange MD MSCE

Dr Christopher Jenson @UNC_Lineberger presenting on #TimeToxicity #HomeTime in older patients with #AML. High intensity treatment improved survival BUT meant most of that time was SPENT IN THE HOSPITAL and/or AWAY from HOME. @ASCO #ASCOQLTY22 cc Dr @guptaarjun90 @erin_bange
account_circle
Fumiko Ladd Chino, MD(@fumikochino) 's Twitter Profile Photo

'You don't live longer, it just seems longer'
steals meaningful moments at home from our patients with serious illness.

➡️fal.cn/3rzeF

'You don't live longer, it just seems longer' #TimeToxicity steals meaningful moments at home from our patients with serious illness. ➡️fal.cn/3rzeF
account_circle
Penn Center for Health Incentives+Behavioral Econ(@PennCHIBE) 's Twitter Profile Photo

'Early in medical school, we learned that only 20% of healthcare occurs within a doctor’s office. The other 80% originates outside the medical setting, where social determinants of health — one’s home, work, etc — are far more influential' Carmen Guerra everydayhealth.com/lung-cancer/wo…

account_circle
Tim Brown, MD MSCE(@TimothyJBrownMD) 's Twitter Profile Photo

We’re also appreciative of the patients who were willing to participate and the manuscript reviewers JAMA Network Open who strengthened the paper and it’s conclusions

account_circle
Erin Bange MD MSCE(@erin_bange) 's Twitter Profile Photo

I am incredibly excited to join the MSK team and help improve patient care with some awesome health services researchers!

account_circle
Tim Brown, MD MSCE(@TimothyJBrownMD) 's Twitter Profile Photo

We’re currently testing if patients without symptoms of immunotherapy-related toxicity identified by SMS can be triaged to fast-track IO infusions without an associated clinic visit. See more ⬇️⬇️ w all-star team Erin Bange MD MSCE Ronac Mamtani Kerry Coughlin, MSW (she/her) Penn Cancer Innovation

account_circle
Mat Angelos(@Mat_Angelos) 's Twitter Profile Photo

Check out our phase 1 CAR-M study in progress at the Developmental Therapeutics session Sunday AM. Excited to meet you at 327b and discuss other new cell therapy work at Kim Reiss Binder (Kim Reiss)

account_circle
Penn Cancer Innovation(@PC3Innovation) 's Twitter Profile Photo

1⃣ in 5⃣ patients receiving immunotherapy may experience a related adverse event. PC3I's Tim Brown, MD MSCE Erin Bange MD MSCE Ronac Mamtani developed a @JamaOnc to support clinician-patient conversations about these events.
Check it out and share:
bit.ly/3bnBq7r

account_circle
Tim Brown, MD MSCE(@TimothyJBrownMD) 's Twitter Profile Photo

Immune checkpoint inhibitors are used to treat many types of cancer, but talking with patients about immunotherapy can be confusing. Ronac Mamtani Erin Bange MD MSCE and I developed a JAMA Oncology Patient Page to help clinicians and patients with this conversation. jamanetwork.com/journals/jamao…

account_circle
Penn Cancer Innovation(@PC3Innovation) 's Twitter Profile Photo

🚨 PC3I is hiring a Clinical Research Coordinator! 🚨

We are seeking someone to implement day to day operations for innovative research projects and strategic initiatives. Join our growing team >> bit.ly/3frVYhw

account_circle
Santosh Vardhana(@SantoshVardhana) 's Twitter Profile Photo

So proud that the first paper from Vardhana Lab, an equal collaboration with Ronac Mamtani and Alex Huang's lab, is out today in Nature Medicine: rdcu.be/ckYst. I posted a long tweetorial about this study when it was a preprint, but a few additional thoughts:

account_circle